BrightSpring Health Services Inc (BTSG) is overvalued and Veeva Systems Inc (VEEV) is overvalued.
Both trade above our estimate of their intrinsic value. VEEV is the closer of the two: -74%, against -81% for BTSG.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 11.7% (average of 3 methods) values the shares at $31.17; the price of $56.55 is 81% above that value, and 69% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
Discounting its cash flows at 9.8% (average of 3 methods) values the shares at $149.85; the price of $260.91 is 74% above that value, and 74% of that value comes from beyond year five.
Leak Score 50/100 on 8 of 12 signals
| Metric | BTSG | VEEV |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $56.55 | $260.91 |
| Intrinsic value | $31.17 | $149.85 |
| Margin of safety | -81% | -74% |
| Leak Score | 14/100 (3/12) | 50/100 (8/12) |
| Market cap | $11.2B | $42.2B |
| Revenue growth, 5 years | 18.3% | 16.9% |
| Operating margin | 3.7% | 29.9% |
| Net margin | 2.0% | 29.3% |
| Return on equity | 13.1% | 14.4% |
| Debt to equity | 1.17 | 0.02 |
| P/E | 42.2x | 42.9x |
| Forward P/E | 24.5x | 25.4x |
| P/B | 5.5x | 5.7x |